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The potential of human mesenchymal stem cells (hMSCs) for allogeneic cell therapies has created a large amount of interest.
However, this presupposes the availability of efficient scale-up procedures. Promising results have been reported for stirred
bioreactors that operate with microcarriers. Recent publications focusing on microcarrier-based stirred bioreactors have
demonstrated the successful use of Computational Fluid Dynamics (CFD) and suspension criteria (𝑁
𝑆1𝑢
,𝑁
𝑆1
) for rapidly scaling up
hMSC expansions from mL- to pilot scale. Nevertheless, one obstacle may be the formation of large microcarrier-cell-aggregates,
which may result in mass transfer limitations and inhomogeneous distributions of stem cells in the culture broth. The dependence
of microcarrier-cell-aggregate formation on impeller speed and shear stress levels was investigated for human adipose derived
stromal/stem cells (hASCs) at the spinner scale by recording the Sauter mean diameter (𝑑
32
) versus time. Cultivation at the
suspension criteria provided 𝑑
32
values between 0.2 and 0.7mm, the highest cell densities (1.25 × 106 cells mL−1 hASCs), and
the highest expansion factors (117.0 ± 4.7 on day 7), while maintaining the expression of specific surface markers. Furthermore,
suitability of the suspension criterion𝑁
𝑆1𝑢
was investigated for scaling up microcarrier-based processes in wave-mixed bioreactors
for the first time.
1. Introduction
Cell-based therapies have become increasingly important
in the field of regenerative medicine, as global revenues of
approximately 1 billion US$ indicate [1, 2]. There has been
an obvious growing interest in hMSCs, particularly in those
that have shown great potential for a wide range of allogeneic
therapies (e.g., dry eye-related macular degeneration, dia-
betes, Crohn’s disease, graft versus host disease, and acute
myocardial infarction [1, 3–8]). By September 2015, 171
Phase 1, 2, and 3 clinical trials with hMSCs had been run
(https://www.clinicaltrials.gov/), a fact that comes as no
surprise. Due to their existence in postnatal tissues (e.g.,
adipose tissue, bone marrow, umbilical tissue, blood, and
peripheral blood) and lower regulatory restrictions than for
embryonic stem cells, hMSCs are more easily accessible and
more widely accepted for clinical applications [9–14]. The
large amount of hMSCs required for one single therapeutic
dose (35–350 million cells per dose) explains the demand for
efficient and scalable in vitro expansion procedures [1, 15].
Although static stacked plate systems, with up to 40 layers,
provide the desired cell numbers of up to 1 × 109 cells in
semicommercial and commercial production processes, it
is difficult to ensure stem cell quantity and quality as the
numbers of layers increase [16, 17].
Microcarrier-based bioreactors were identified as an
alternative to planar cultivation technology that could meet
the requirements in terms of production scale, bioprocess
economics, and optimization [18]. The highest hMSC densi-
ties (1.4 × 105–0.8 × 106 cellsmL−1) and maximum expansion
factors (EFs) between 40 and 50 were achieved in stirred
bioreactors operated with solid or porous microcarriers in
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a serum-supplemented (5–10% fetal bovine serum albumin,
FBS) culture medium, cultivated for up to 21 days [19–30].
In order to successfully scale up microcarrier-based stirred
bioreactor processes with hMSCs, Hewitt et al. [24] and
Rafiq et al. [19] applied the suspension criterion 𝑁
𝑆1
. This
criterion that takes the high shear sensitivity [31, 32] of
hMSCs into account can be attributed to Zwietering [33] and
his studies from the late 1950s.𝑁𝑆1 represents the minimum
impeller speed that just fully suspends the microcarriers
at minimal shear stresses. However, it does not guarantee
a homogenous dispersion of all microcarriers throughout
a culture medium. Kaiser et al. [27] and Schirmaier et al.
[20] introduced 𝑁𝑆1𝑢 criterion and proposed the antecedent
prediction of the fluid flow pattern and hydrodynamic forces
using Computational Fluid Dynamics (CFD) and Particle
Image Velocimetry (PIV).𝑁
𝑆1𝑢
criterion represents the lower
limit of 𝑁
𝑆1
criterion and allows for local movement of the
microcarriers along the bioreactor bottom, but with none of
the microcarriers at rest. By using𝑁
𝑆1𝑢
criterion, Schirmaier
et al. [20] have achieved the highest number (1 × 1010) of both
hASCs and EFs (41.7 within 7 days) in microcarrier-based
stirred bioreactors at the pilot scale (35 L working volume)
to date. However, as shown by Ferrari et al. [34], with bone
marrow-derived hMSCs grown in spinner flasks on dextran
microcarriers (Cytodex 1), large microcarrier-cell-aggregates
can appear, whichmay result inmass transfer limitations and,
finally, loss of stem cell properties, reduced cell growth, and
even cell death. This raises the question of whether there
is a dependence between microcarrier-cell-aggregate size,
impeller speed, shear stress, cell quantity, and cell quality.
For this reason, one aim of our study was to investi-
gate time-dependent hASC growth in spinners at different
impeller speeds (taking the suspension criteria into account)
and shear stress levels, while also taking themicrocarrier-cell-
aggregate size into account. All these investigations are based
on the previously published characterization investigations
(suspension studies, CFD simulations, and PIV measure-
ments) of our group (Kaiser et al. [27]). The second aim was
to examine whether it is possible to use 𝑁
𝑆1𝑢
criterion for
hMSCmass production processes in wave-mixed bioreactors
with one-dimensional motion. In this type of bioreactor,
mass transfer is accomplished by a propagating wave, whose
intensity can be regulated by the bioreactor’s rocking angle,
rocking rate, and filling level. The wave is induced by rocking
a fixed, surface-aerated bag [35–38] containing the medium
and microcarriers to which the cells attach. Although this
bioreactor type is well established in seed inoculum and
microcarrier-based vaccine production processes with con-
tinuous animal cell lines, there are only two publications that
describe its applicability to the expansion of hMSCs [39, 40].
Timmins et al. [39] cultivated human placental MSCs on
CultiSpher-S microcarriers and achieved EFs of up to 16.3
within 7 days under low O2 (5%) conditions. In normoxic
conditions Akerstro¨m [40] grew nonspecified hMSCs on
Cytodex 3 microcarriers over 18 days and harvested 20 × 106
cells, corresponding to an EF of 6. We decided to work with a
BIOSTAT CultiBag RM 2L (optical version) and to adopt the
shear stress at𝑁
𝑆1𝑢
for hASCs in spinner flasks (4.9 × 10−3 to
0.18Nm−2), which required previous suspension, CFD, and
PIV investigations of the cultivation system.
2. Materials and Methods
2.1. Bioengineering Characterizations of
the BIOSTAT CultiBag RM 2L
2.1.1. Suspension Studies. The suspension experiments were
carried out with a specially developed medium from Lonza
containing 5% FBS and two different types of polystyrene-
basedmicrocarriers (Pall, USA).Three different working vol-
umes (0.5 L, 1.0 L, and 1.5 L) and microcarrier solid fractions
ranging from 0.7 to 2.1% were tested. The polystyrene-based
microcarriers consist of particles with densities between 1090
and 1150 kgm−3 (MC-1) and between 1022 and 1030 kgm−3
(MC-2) and diameters between 160 and 200 𝜇m and between
125 and 200𝜇m, respectively. The resulting nominal growth
surfaces per gram were approximately 515 cm2 and 360 cm2.
MC-1 was applied to establish an initial multiregression
model for the prediction of the suspension criteria (𝑁𝑆1𝑢,
𝑁𝑆1) in the wave-mixed system and has no significance for
the further cultivation studies described in Section 2.2.
In order to better assess the bioreactor bottom, a trans-
parent, rigid rocking platformmade of acrylic glass was used.
In addition, a mirror was placed below the rocking platform
to improve optical accessibility of the bioreactor bottom.
Suspension characteristics were investigated for different
rocking angles between 4∘ and 10∘. The rocking angle was
kept constant and the rocking rate was increased stepwise up
to a maximum of 35 rpm. 𝑁
𝑆1
criterion for the wave-mixed
bioreactor was defined as the combination of rocking rate and
rocking angle, where themicrocarriersmake contact with the
reactor bottom for no longer than 1 s. Likewise, for the stirred
bioreactors,𝑁
𝑆1𝑢
criterion was the lower limit of𝑁
𝑆1
.
2.1.2. CFD. The fluid flow inside the BIOSTAT CultiBag
RM 2L was modelled using the Fluent 15 finite volume
solver (ANSYS, Inc., USA). Due to the motion of the liquid
interface, the Volume-of-Fluid (VOF) approach was used for
the simulations. For this purpose, a set of single momentum
equations, based on the Reynolds-averaged Navier-Stokes
(RANS) equations, were solved. The interface between the
phases was tracked over time using a balance equation for the
fractional volume, which can be described for the 𝑞th phase
by the following:
𝜕
𝜕𝑡
(𝛼𝑞𝜌𝑞) + ∇ (𝛼𝑞𝜌𝑞?⃗?𝑞) = 0. (1)
The terms ?⃗?
𝑞
,𝛼
𝑞
, and 𝜌
𝑞
in (1) denote the fluid velocity vector,
the fluid density, and the volume fraction of the 𝑞th phase. By
assuming a shared velocity field among the phases, a single
momentum balance equation (see (2)) was solved for the
entire fluid domain:
𝜕
𝜕𝑡
(𝜌?⃗?) + ∇ (𝜌
𝑞
?⃗??⃗?) = −∇𝑝 + ∇ [𝜇 (∇?⃗? + ∇?⃗?
𝑇
)]
+ 𝜌?⃗? + ?⃗?,
(2)
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where ?⃗? defines all the volumetric forces except gravity. In (2),
the viscosity and the density are weighted mean values:
𝜌 = ∑𝛼𝑞𝜌𝑞,
𝜇 = ∑𝛼
𝑞
𝜇
𝑞
(3)
whose phase volume fractions are computed based on the
following constraint:
𝑛
∑
𝑞=1
𝛼
𝑞
= 1. (4)
A good approximation for the rocker-type motion of the
bioreactor was described by a harmonic oscillation function,
where the deflection angle (𝜑) at the time point 𝑡 can be
predicted by the following equation:
𝜑
𝑡
= 𝜑max ⋅ sin (𝜔𝑡) . (5)
This resulted in (6), which was entered into Fluent as a user-
defined function and describes the movement of the bag as a
solid body:
𝜔
𝑡
= 𝜔(𝜑max ⋅
𝜋
180
) ⋅ cos (𝜔 ⋅ 𝑡) . (6)
Turbulent flow conditions were modelled using 𝑘-𝜔 SST
model, where a set of transport equations for the turbulent
kinetic energy 𝑘, the turbulent dissipation rate 𝜀, and the
specific turbulent dissipation rate 𝜔 were solved. Detailed
information of the model is provided in [41, 42]. The volume
of the pillow-like bag was discretized into 1.5 × 106 tetrahe-
dral control volumes, guaranteeing acceptable computational
accuracy and a tolerable computational turnaround time.
The simulations were performed for three different working
volumes (0.5 L, 1.0 L, and 1.5 L) by patching the corresponding
liquid phase. Rocking rates (14–35 rpm) and rocking angles
(4–10∘) were selected based on the results of the suspension
studies. The velocity-pressure coupling and the prediction
of volume fractions were accomplished using the SIMPLE
algorithm and geo-reconstruction method provided by Flu-
ent. The time-step size was fixed at 0.005 s. Convergence was
assumed when the residuals dropped below 10−5. However,
the number of iterations per time-step was restricted to 100
in order to limit the central processing unit turnaround time.
2.1.3. PIV. PIV measurements were performed to verify the
CFD model. For this purpose, a FlowMaster PIV system
(LaVision, Germany) in conjunction with a double-pulsed
Nd:YAG laser that generated a 1mmthick laser sheetwas used
(𝜆 = 532 nm, litron lasers, UK). The fluid flow pattern in
the BIOSTAT CultiBag RM 2L was captured at two different
positions (from the side and from below). For the side
recordings, a specially constructed bag with a piece of acrylic
glass along the centreline was used. This enabled process
images to be recorded at the edges of the bag along the vertical
laser plane, which was located in the middle of the half bag.
The recordings from below were carried out for the whole
bag. For this purpose, again a transparent rocking platform
in combination with a mirror below the platform was used in
order to provide optical accessibility to the reactor bottom.
The laser sheet was horizontally positioned 1 cm above the
bag bottom. An Imager Pro X4 CCD camera (LaVision,
Germany) with a resolution of 2048 × 2048 pixels was used
to acquire images and was positioned at a 90∘ angle relative
to the laser field for the side measurements and directly on
the mirror for the bottom investigations. DaVis® 8.2 software
(LaVision, Germany) was used to control the camera, the
traverse system, the laser, image acquisition, and flow field
prediction. In order to visualise the fluid flow pattern,
rhodamine-coated fluorescent particles with a density of
1.19 kg/m−3 (LaVision) were added to the bag. A set of 800
double frame images per position were recorded in order to
obtain statistically significant results, based on an interro-
gation window of 8 × 8 pixels with an overlap of 50%. The
measurements were performed for three working volumes
(0.5 L, 1.0 L, and 1.5 L), different rocking angles (6∘ and 10∘),
and rocking rates (15 rpm, 25 rpm, and 35 rpm). Phase-locked
measurements were recorded by means of a photoelectric
barrier focused on the edge of the rocking platform. For each
experimental set, images were made during the harmonic
oscillation at momentary deflection angles of 4∘ to 10∘.
2.2. Cultivation Studies
2.2.1. Cells, Microcarriers, and Medium. Cryopreserved
hASCs (Lonza Cologne GmbH, Germany) obtained from
a single informed and consenting donor (hASCs, third
passage, population doubling level of 10) were used for
all expansions taking place under serum-reduced (5%
FBS) conditions in a specially developed medium (Lonza,
USA) on polystyrene-based microcarriers (Pall, USA). The
microcarriers (MC-2) used had densities ranging from 1090
to 1150 kgm−3, particle sizes between 125 and 212 𝜇m, and a
mean surface area of approximately 360 cm2 g−1.
2.2.2. Analytics. Off-line samples were taken daily to deter-
mine glucose, lactate, glutamine, and ammonium by biosen-
sors (enzymatic) and ion selective electrodes in the Bio-
Profile 100Plus (Nova Biomedical, USA). In addition, 4󸀠,6-
diamidino-2-phenylindole (DAPI) staining was performed
and microcarrier-cell-aggregates were measured. The aggre-
gate measurements were performed based on macroscopic
(hand camera) and microscopic pictures, which were ana-
lyzed by a user-defined MATLAB (MathWorks, Inc., USA)
script and DaVis® 8.2 software. The cell densities were mea-
sured in triplicate per sample using aNucleoCounter NC-200
(ChemoMetec, Denmark). All microcarrier-cell-aggregates
contained in the spinner flasks and the 2 L bag were washed
with TrypLE Select (Gibco by Life Technologies, USA) and
incubated for 30min at 37∘C before the hASC harvest.
Flow cytometric investigations (MACSQuant device
from Miltenyi Biotec, Germany) were always performed
after cell harvesting with microcarrier-free, purified hASCs
samples. The samples were stained with fluorochrome-con-
jugated anti-humanCD14, CD20, CD34, CD45, CD73, CD90,
and CD105 antibodies (MSC Phenotyping Kit, Miltenyi
Biotec, Germany), which represent minimal surface markers
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recommended by the International Society for CellularTher-
apy.
2.2.3. Corning Spinner Flask Cultivations. In order to inves-
tigate the influence of different impeller speeds on cell
growth and aggregate formation, six different impeller speeds
(25 rpm, 43 rpm, 𝑁
𝑆1𝑢
= 49 rpm, 𝑁
𝑆1
= 63 rpm, 90 rpm, and
120 rpm) were studied under low-serum conditions (5%)
in spinner flask (Corning, USA) experiments for MC solid
fractions of 0.01%. For each condition, two spinner flasks
(100mL culture volume) with mean microcarrier growth
surfaces of 360 cm2 were inoculated with cryopreserved
hASCs (3 × 103 cells cm−2) and cultivated for 8 days at 37∘C,
5% CO
2
, and 80% humidity (normoxic).
Before inoculation, the microcarrier suspensions were
equilibrated for 1 h, as recommended by the vendor. After
inoculation, a 4 h attachment phase was realized to support
cell attachment before the impeller was switched on. On day
4 after inoculation, 50% of the growth medium was replaced
with fresh, preheated medium. For this purpose, the MCs
with the attached cells were allowed to settle, before 50%
of the medium was replaced with fresh, preheated medium.
Cell attachment and harvest procedures were developed and
optimized by Schirmaier et al. [20].
2.2.4. BIOSTATCultiBag RM2LProof-of-Concept Cultivation.
The solid fraction of the polystyrene-based microcarriers
was adjusted to 1.43% (7’722 cm2) for the proof-of-concept
cultivation in the BIOSTATCultiBag RM 2L. Equilibration of
themicrocarriers and inoculation of the cells were performed
in two 1 L shake flasks. For this purpose, the microcarrier
suspension was incubated overnight at 37∘C, 5% CO
2,
and
80% humidity. Each of the shake flasks was inoculated with
6500 cells cm−2 of the microcarriers for the cryopreserved
hASCs. To promote cell attachment, a 20 h static attachment
phase was found to be most suitable after inoculation.
Afterwards, a portion of the microcarrier suspension (mean
growth surface = 360 cm2)was transferred into a spinner flask
as a control. The hASCs in the spinner flasks were cultivated
as described for the spinner experiments in Section 2.2.3
(impeller speed = 49 rpm𝑁𝑆1𝑢). The remaining microcarrier
suspension (mean growth surface = 7’362 cm2) was trans-
ferred into a BIOSTAT CultiBag RM 2L. Preheated medium
was then added to achieve a total working volume of 1.5 L.
To achieve similar shear stresses as in the spinner flask,
the BIOSTAT CultiBag RM 2L was overfilled with 500mL
medium. The rocking angle and rocking rate were set based
on the biochemical engineering investigations (𝑁
𝑆1𝑢
= 4∘ and
31 rpm; Section 3.2.1). The hASCs were cultivated for 9 days
at 37∘C, pH 7.3, and 0.05 vvm. On day 5 after inoculation,
the rocker platform was switched off and the bag was hung
up to allow the MCs with attached cells to settle down. After
approximately 15min, 50% of the culture medium could be
replaced with negligible cell and microcarrier lost.
3. Results and Discussion
3.1. Corning Spinner Flask. Figure 1(a) shows time-depend-
ent profiles of living cell densities measured in the spinner
flask runs. The impeller speed dependent growth parameters
are summarized in Table 1. Maximum living cell densities
between (0.25 ± 0.02) × 106 hASCs mL−1 and (1.25 ± 0.05)
× 106 hASCs mL−1 were found 7 days after inoculation. The
highest living cell densities were achieved at impeller speeds
of 49 rpm and 63 rpm for𝑁𝑆1𝑢 and𝑁𝑆1 criteria. Cell densities
at the suspension criteria were four to five times higher than
the living cell density at 120 rpm. This can be ascribed to the
twofold to threefold lower local shear stress levels and the
threefold to fivefold lower specific power inputs at 𝑁
𝑆1𝑢
and
𝑁
𝑆1
(Table 1).
During the exponential growth phase, the fastest hASC
growth (doubling time of 23.7 ± 0.1 h) was calculated for
the spinner flask cultivation at 49 rpm (𝑁
𝑆1𝑢
). The slowest
hASC growth (doubling time of 41.3 ± 0.1 h) was found at
120 rpm. In spite of lower shear stresses, the hASCs also
grew more slowly at impeller speeds below the suspension
criteria. This might have been due to insufficient mixing and
the resulting sedimentation of the microcarriers, since not all
MCs were permanently suspended. Mass transfer limitations
that impair cell growth can occur.
It can clearly be seen from Figure 1(b) that statistically
significant, higher EFs (one-way ANOVA with pairwise
comparison; Holm-Sidak method, 𝑝 < 0.05, 𝑛 = 2) were
obtained for𝑁𝑆1𝑢 (117 ± 4.7) and𝑁𝑆1 (97.4 ± 3.7) criteria.The
lowest EFs {(28.5 ± 5.1) and (19.4 ± 1.3)} were achieved at the
highest impeller speeds, which were up to four times lower
than those at the lower impeller speeds of 25 rpm and 43 rpm.
The growth results (cell densities, doubling times, and
EFs) support our hypothesis that operating a microcarrier-
based stirred bioreactor at the lower suspension criterion
𝑁𝑆1𝑢 ensures maximum hMSC growth.
As is obvious from Table 2, the highest lactate production
rate was determined at 120 rpm, while the maximum living
cell density was the lowest. In contrast, the specific lactate
production rate at 49 rpm (𝑁
𝑆1𝑢
) was around 3.6 and 1.7
times lower compared to 120 rpm and 25 rpm. Furthermore,
𝑌lac/gluc indicates that the metabolization of glucose into
energy ismore efficient, whenworking at𝑁
𝑆1𝑢
criterion.After
7 days of cultivation, a decrease in the living cell density
was observed, which was independent of the cultivation
parameters. Because substrate andmetabolite limitations can
be excluded (concentrations at the end of the cultivation:
glucose/glutamine ≥ 14.8/4.0mmol L−1; lactate/ammonium
≤ 24.8/1.51mmol L−1; [43, 44]), this might be due to the size
of themicrocarrier-cell-aggregates, which impair cell growth.
Figure 2(a) clearly shows the microcarrier-cell-aggregate
development. The time-dependent profiles of the Sauter
mean diameters (𝑑
32
) are shown for all tested impeller speeds.
As expected, the highest Sauter mean diameter of up to 3.18 ±
0.42mmwas measured at the lowest impeller speed (25 rpm)
on day 8 and was significantly higher compared to the other
conditions. At this impeller speed, accumulation of larger
aggregates below the impeller was observed. These findings
are in good agreement with our previous CFD investigations
published by Kaiser et al. [27]. Due to the circulation loop
induced directly below the impeller, lower fluid velocities
occur in this region, which promote the sedimentation of
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Figure 1: Results of hASC cultivations in the Corning spinner flasks. (a) Time-dependent profiles of living cell densities. The dotted lines
represent the simulated growth characteristics of the hASCs in the exponential growth phase, based on the calculated specific growth rates.
The black arrow indicates the 50% medium exchange on day 4. (b) Comparison of maximum expansion factors calculated for day 7. A one-
way ANOVA (Holm-Sidak method, 𝑛 = 2; 𝑝 < 0.05) with pairwise comparison was performed for the maximum EFs. ns = not significant.
The error bars represent the standard deviations of the EF given by the two cases of independent spinner cultivation per condition.
larger aggregates. The Sauter mean diameter at the lowest
impeller speed was approximately seven times higher than
at the suspension criteria. Interestingly, the Sauter mean
diameter of 0.55 ± 0.06mm on day 7 at 120 rpm was not
significantly lower than those of the suspension criteria (𝑁
𝑆1𝑢
:
0.58 ± 0.07mm; 𝑁
𝑆1
: 0.47 ± 0.03mm), demonstrating that
the threefold higher specific power input had no significant
effect on the overall microcarrier-cell-aggregate size in the
spinner flasks. The results indicate that the reduction in
the living cell density might be ascribed to two main rea-
sons: (I) too high local shear stresses (0.437Nm−2) which
came along with higher lactate concentrations and (II) mass
transfer limitations due to large microcarrier-cell-aggregate
sizes (𝑑
32
> 0.6mm) or too low impeller speeds (<49 rpm).
Figures 2(b) and 2(c) illustrate DAPI staining picture of a
microcarrier-cell-aggregate sample taken from a run (day 7)
at𝑁
𝑆1𝑢
criterion.
At the end of the cultivation (days 7 and 8), themajority of
the cells were observed between the microcarriers, especially
in the bigger microcarrier-cell-aggregates (Figure 2(c)). A
reduction of cell density prevails at Sauter mean diameters
of approximately 0.6mm, which was also noted at the end of
the cultivation.
Any influence on the expression of specific surface mark-
ers (CD14, CD20, CD34, CD45, CD73, CD90, and CD105)
was, however, not discovered, either at the maximum
impeller speeds and resulting shear stress levels (maximum
specific power inputs of 3.63Wm−3 and maximum local
shear stress level of 0.437Nm−2) or at the maximum Sauter
diameters (3.2mm) that reflected the maximum micro-
carrier-cell-aggregation size. Because all flow cytometric
results were in good agreement with each other, only those
measured in samples from spinner runs at 𝑁
𝑆1𝑢
are shown
in Figure 3. The cells were highly positive (>95%) for CD73,
CD90, and CD105 surfacemarkers.The hematopoietic mark-
ers CD34 and CD45 as well as CD14 and CD20 were absent
(<2%) from all samples.
3.2. BIOSTAT CultiBag RM 2L
3.2.1. Suspension Characteristics. In general, dune-like depo-
sits of microcarriers were seen at rocking rates significantly
below𝑁𝑆1𝑢 criterion.This effect was independent of the rock-
ing angle and can be explained by the oscillating fluid flow,
in which a type of constructive and destructive interference
takes place. As rocking rates increased the dune-like deposits
decreased, due to the higher level of mixing. Almost com-
plete suspension of the microcarriers was observed at 𝑁𝑆1𝑢
criterion. For all of the investigated conditions,𝑁𝑆1 criterion
was fulfilled at 2.5–8.3% higher rocking rates (approximately
1 rpm). The results indicate that the difference between 𝑁
𝑆1𝑢
and 𝑁
𝑆1
criteria in wave-mixed systems is much lower than
in stirred bioreactors (20–40%) [21, 22, 27, 45, 46]. This
phenomenon can be explained by the periodical deceleration
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Figure 2: Microcarrier-cell-aggregate formation during the cultivation of the hASCs. (a) Time-dependent profiles of the Sauter mean
diameters (𝑑
32
) for all tested impeller speeds. (b) and (c) DAPI staining picture of microcarrier-cell-aggregate sample taken from a run
at𝑁
𝑆1𝑢
suspension criterion (49 rpm, day 7). White arrow indicates that the cell growth takes place over the entire microcarrier surface and
between the microcarriers. Focal plane was set in order to see the cell growth between the microcarriers.
and acceleration of the particles in wave-mixed bioreactors.
The determined rocking rates that fulfil 𝑁
𝑆1𝑢
criterion for
rocking angles between 4 and 10∘ ranged between 12 and
26 rpm for a 0.5 Lworking volume, between 15 and 32 rpm for
1.0 L, and between 17 and 35 rpm for 1.5 L.The corresponding
rocking rates for 𝑁𝑆1 criterion were in a comparable range.
Surprisingly, linear relationships were found between rocking
rates and rocking angles for each specific microcarrier solid
fraction. Based on amultiple regression analysis a correlation
(see (7)) for𝑁𝑆1𝑢 criterion was found:
𝑁
𝑆1𝑢
= −2.079 ⋅ 𝜑max + 7.526 ⋅ 𝑉𝑓 − 0.119 ⋅ 𝑚MC
+ 0.00537 ⋅ 𝐴MC + 0.0329 ⋅ 𝜌MC − 6.039
𝑅 = 0.977,
(7)
where 𝜑max [
∘] defines the rocking angle, 𝑉
𝑓
[L] the work-
ing volume, 𝑚MC [g] the amount of microcarriers, 𝐴MC
[cm2 100mL−1] the specific growth surface, and 𝜌MC [kgm
−3]
the density of the microcarriers. The maximum deviation
between the predicted and the measured values was approxi-
mately 3 rpm and, therefore, was acceptable. In Figure 4,𝑁
𝑆1𝑢
criterion is shown as a contour plot for the three different
working volumes. As can be seen, the dependence of 𝑁
𝑆1𝑢
criterion on the rocking angle decreases as the working
volume rises.
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Table 1: Summary of growth parameters, CFD-predicted specific power inputs (𝑃/𝑉), and local shear stress (LSS) levels.
𝑁 [rpm] 𝑃/𝑉 [Wm−3] LSS
a
[10−3Nm−2]
Total cell numbers
on day 7 [107 cells]
Living cell
density on day 7
[106 cellsmL−1]
EFs [—] 𝜇max and 𝑡𝑑
[h−1] and [h]
25 0.21 3.21/69 8.1 ± 0.1 0.81 ± 0.01 71.4 ± 0.2 0.026 ± 0.00126.7 ± 0.1
43 0.65 4.43/142 6.2 ± 0.6 0.62 ± 0.06 79.6 ± 3.2 0.022 ± 0.00131.5 ± 0.2
49 0.80 4.96/187 12.5 ± 0.5 1.25 ± 0.05 117.0 ± 4.7 0.029 ± 0.00123.7 ± 0.1
63 1.24 6.72/224 11.1 ± 0.6 1.11 ± 0.06 97.4 ± 3.7 0.028 ± 0.00124.8 ± 0.2
90 2.24 10.22/325 3.7 ± 0.7 0.37 ± 0.07 28.5 ± 5.1 0.020 ± 0.00234.4 ± 0.4
120 3.63 13.56/437 2.5 ± 0.2 0.25 ± 0.02 19.4 ± 1.3 0.017 ± 0.00141.3 ± 0.1
aLSS; local shear stress given with volume-weighted mean/maximum values. LSS and 𝑃/𝑉were adapted from Kaiser et al. [27].
Table 2: Specific metabolic consumption and production rates.
𝑁 [rpm] −𝑞gluc
[pmol cell−1 d−1]
𝑞lac
[pmol cell−1 d−1]
𝑌lac/gluc
[mmolmmol−1]
𝑞NH4+
[pmol cell−1 d−1]
𝑌NH4+/gln
[mmolmmol−1]
25 −1.86 ± 0.01 4.31 ± 0.03 2.87 ± 0.01 0.259 ± 0.004 2.65 ± 0.41
43 −2.30 ± 0.20 4.39 ± 0.30 1.94 ± 0.30 0.252 ± 0.003 2.66 ± 0.29
49 −1.58 ± 0.11 2.43 ± 0.17 1.55 ± 0.11 0.090 ± 0.001 2.46 ± 0.46
63 −1.08 ± 0.23 2.92 ± 1.04 2.51 ± 0.39 0.191 ± 0.052 2.36 ± 0.49
90 −4.09 ± 0.52 7.78 ± 1.39 1.89 ± 0.10 0.596 ± 0.133 2.43 ± 0.11
120 −5.07 ± 0.19 8.82 ± 0.11 1.74 ± 0.04 0.878 ± 0.085 2.57 ± 0.05
−𝑞gluc: specific glucose consumption rate; 𝑞lac: specific lactate production rate; 𝑞NH4+ : specific ammonia production rate;𝑌lac/gluc: specific lactate yield per unit
glucose; 𝑌NH4+/gln: specific ammonia yield per unit glutamine. (𝑛 = 2).
3.2.2. Fluid Flow. For a rocking rate of 25 rpm and a rock-
ing angle of 10∘, contour plots of the CFD-predicted fluid
flow velocities along the mid bioreactor plane are shown
in Figure 5(a). Significantly higher fluid flow velocities
(0.75m s−1) occur at maximum deflection for 0.5 L working
volume. This was expected, since the motion of the free sur-
face increases at lower working volumes. A clearly dampened
fluid flow with fluid flow velocities of up to 0.55m s−1 at
maximum deflection was predicted for the higher working
volume of 1.5 L. This trend can also be seen for the volume-
weighted mean fluid flow velocities in Figure 5(b) and was
independent of the rocking rate and the rocking angle. The
maximum volume-weighted mean fluid flow velocities at
0.5 L, 25 rpm, and 10∘ were approximately 1.8 times higher
than those at 1.5 L (0.14m s−1). Furthermore, the simulation
results indicated that a change in the rocking angle has a
higher effect on the fluid flow velocities than a change in the
rocking rate. The lowest volume-weighted mean fluid flow
velocities of up to 0.05m s−1 were obtained at 31 rpm and 4∘
and corresponded to𝑁
𝑆1𝑢
criterion in the BIOSTATCultiBag
RM 2L (1.43% microcarrier solid fraction). Kaiser et al. [27]
predicted volume-weighted mean fluid flow velocities of up
to 0.06m s−1 for 𝑁
𝑆1
criterion in the spinner flask. Thus,
working at 1.5 L is preferable for the expansion of the hASCs,
when comparable flow conditions to those in spinner flasks
are desired.
3.2.3. Shear Stress and Specific Power Input. An overview
of the shear stress distributions and specific power inputs
present in the BIOSTAT CultiBag RM 2L (including working
volume, rocking angle, and rocking rate) is summarized
in Table 3. The shear stresses were calculated according
to Wollny [47], where logarithmical normal distributions
similar to those of stirred bioreactors were obtained [27, 48].
Unlike stirred bioreactors, the fluid flow behaviour in wave-
mixed systems cannot be assumed to be constant. Hence,
shear stress distributions were calculated for each deflection
angle during a single bag oscillation.
In Figure 6(a), angle-dependent profiles of volume-
weighted mean shear stresses are exemplarily presented for
three different working volumes at 10∘ and 25 rpm. The
local shear stresses follow a periodic oscillation, where the
highest values occur at maximum deflection. This comes as
no surprise, since the flowing fluid is decelerated to a lower
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93.2%
CD14− , CD20− , CD34− , CD45−
CD73+ , CD90+ , CD105+
Figure 3: Results of flow cytometric analysis (FACS) of hASCs at the end of the cultivation at 49 rpm (day 7).The gates of the flow cytometric
analysis were set based on isotype controls.
Table 3: Summary of predicted shear stress levels and specific power inputs in the BIOSTAT CultiBag RM 2L.
Working volume [L] Rocking angle [∘] Rocking rate [rpm] 𝑃/𝑉a [Wm−3] MLSSb [10−3Nm−2]
0.5 4 26 20.61/40.66 5.83/664
0.5 6 22 32.52/53.55 5.44/509
0.5 6 35 156.01/262.60 5.78/597
0.5 8 18 47.71/85.79 29.61/704
0.5 10 14 93.40/149.73 20.61/885
0.5 10 25 144.10/259.76 26.40/3162
1.0 4 29 34.40/65.33 4.91/916
1.0 6 25 53.70/98.16 4.75/1194
1.0 8 20 32.14/53.35 1.09/289
1.0 10 15 81.10/123.77 5.68/1012
1.0 10 25 118.32/203.76 10.80/4042
1.5 4 31 8.92/17.69 0.49/214
1.5 6 27 17.96/32.45 0.60/256
1.5 8 22 26.56/50.04 0.74/279
1.5 10 16 68.85/105.28 3.15/909
1.5 10 25 95.02/155.46 4.86/2959
a
𝑃/𝑉: mean and maximum values of specific power input. bMLSS: maximum values of local volume-weighted mean and maximum shear stresses over one
period.
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Figure 4: 𝑁
𝑆1𝑢
criterion at the three different working volumes. The contour plots were created on the basis of the measured data and the
multiple regression model.
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Figure 5: Comparison of fluid flow in the BIOSTAT CultiBag RM 2L at three different working volumes (0.5 L, 1.0 L, and 1.5 L). (a) Contour
plots of CFD-predicted fluid flow patterns and fluid flow velocities for three different working volumes. The fluid flow patterns and the fluid
flow velocities are shown for 25 rpm and 10∘. (b) Comparison of volume-weighted mean fluid flow velocities over one period.
velocity and then it accelerates in the other direction. The
highest local shear stresses occurred at the lowest working
volume of 0.5 L, with values that were up to 6 times higher
than the local shear stresses for the 1.0 L and 1.5 L working
volumes. The lowest local shear stress values (0.214Nm−2)
were obtained at 1.5 L, 4∘, and 31 rpm for 𝑁
𝑆1
criterion
and a microcarrier solid volume fraction of 1.43%. These
maximum local shear stresses are similar to those for 𝑁
𝑆1
criterion in the spinner flask. For 10∘ and 25 rpm, the angle-
dependent specific power inputs based on the moment at the
rotational axis are illustrated as an example in Figure 6(b). In
general, the profiles of the specific power inputs correspond
well to the local shear stresses. The highest specific power
inputs appear shortly before the maximum deflection is
reached. The highest specific power input of 262Wm−3 was
determined at 0.5 L, whereas the lowest specific power input
was 17.69Wm−3 and was achieved for 1.5 L, 4∘, and 31 rpm
(𝑁
𝑆1
criterion). The power input results coincide with those
obtained by Lo¨ffelholz et al. [36] and Eibl et al. [35].
3.2.4. PIV Measurements. To validate the numerical models,
a line was set along themeasurement field after analysis of the
PIVdata (see Figure 7, contour plots of PIVdata). For 25 rpm,
10∘, and 1.0 L working volume, the CFD-predicted and PIV-
measured fluid velocities are depicted as an example for the
side (a) and the bottom view recordings (b) in Figure 7. The
measurements were performed at a momentary deflection
angle of 7∘ when lowering the bag. Only minor differences in
the mean relative deviation (𝛿𝑟), of less than 15%, were found
between the predicted CFD and measured PIV data:
𝛿𝑟 =
√(1/𝑋)∑
𝑋
𝑖=1
(𝑋exp
𝑖
− 𝑋sim
𝑖
)
2
√(1/𝑋)∑
𝑋
𝑖=1
𝑋2exp
𝑖
. (8)
The discrepancy between the data can be explained by the
lowest deviations in the measuring angle and by the shape of
the bag, since no fluid structure interactions were considered
in the simulations.The largest deviations occur near the edges
of the bag (see Figures 7(a) and 7(b); l/L
2
0.23–0.38). The
dampening of the fluid flow at higher working volumes was
also seen in the PIV measurements. Looking in addition at
further results (e.g., spatial characteristics of the wave), it
can be postulated that the established VOF model provides
reliable fluid flow predictions.
3.2.5. Proof-of-Concept Cultivation. The proof-of-concept
propagation of the hASCs in the BIOSTAT CultiBag RM 2L
was successful, although the EF after 9 days was approxi-
mately three times lower (6.59 ± 0.56) than that in the control
spinner (Figure 8(a)).The harvest provided 2.85 × 108 hASCs.
Akerstro¨m [40] reported a comparable EF, but over the dou-
ble cultivation time. However, the cultivation process had not
been optimized in terms of the attachment phase performed
in shake flasks and the subsequent inoculation of the cells.
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Figure 6: Angle-dependent profiles of volume-weighted mean shear stress levels (a) and specific power input (b) at 10∘ and 25 rpm and
different working volumes.
CFD simulation
PIV measurement
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
Fl
ui
d 
ve
lo
ci
tie
s (
m
 s−
1 )
0.2 0.4 0.6 0.8 1.0
1.0
0.0
0.0 l/L2
Dimensionless length coordinates l/L2 [—]
(a)
CFD simulation
PIV measurement
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
0.55
0.60
Fl
ui
d 
ve
lo
ci
tie
s (
m
 s−
1 )
0.2 0.4 0.6 0.8 1.00.0
Dimensionless length coordinates l/L2 [—]
1.00.0 l/L2
(b)
Figure 7: Comparison of PIV-measured (symbols) and CFD-predicted fluid flow velocities (solid line) through a horizontal line for side (a)
and bottom view recordings (b). The comparison of the fluid flow velocities is given for operational parameters of 1.0 L, 25 rpm, and 10∘. The
error bars represent the standard deviation calculated over the 800 double frame images. The length coordinates were made dimensionless
by the length of the field of view. The contour plots of the PIV data were scaled from 0.0 to 0.45m s−1.
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The first microcarrier-cell-aggregates were already observed
3 days after inoculation. The diameters of the aggregates
increased during the cultivation and reached amaximum size
of approximately 6mm (only a few aggregates) at the end of
the cultivation. Figure 8(b) shows representatively a DAPI-
stained microcarrier-cell-aggregate sample at the end of the
cultivation.
4. Summary and Conclusions
In this study, the superiority of the suspension criterion𝑁
𝑆1𝑢
for mass propagating hASCs in microcarrier-based stirred
bioreactors was shown. The highest living cell densities and
EFs of hASCs were achieved in stirred cultivation systems.
These results confirm the observations of Kaiser et al. [27],
Schirmaier et al. [20], and Jossen et al. [22].
In spinners, the lowest living cell densities were achieved
at the maximum impeller speed (120 rpm). At this impeller
speed, the maximum shear stresses were 130% higher than
those at𝑁
𝑆1𝑢
. Interestingly, the mean Sauter diameter, which
was measured to evaluate the time-dependent microcarrier-
cell-diameter, was lower than those at 25 rpm but comparable
to those at the lower suspension criterion. Independent of
the impeller speed, a decrease in the living cell densities was
observed for mean Sauter diameters of 0.6mm, even though
shear stress levels were low and substrate limitation was
excluded at the spinner scale.The reduction of the cell density
might be a result of an undersupply of the cells in the centre
of large microcarrier-cell-aggregates, although a change in
the expression profile of the specific surface markers was
not found. However, as reported for carrier-free cultivations
with hASCs, cell aggregate diameters of 0.2mm may already
be critical and reduce the cell proliferation potential [34,
49]. Consequently, subsequent microcarrier-based produc-
tions of hASCs in spinners and stirred bioreactors not only
should include extended cell quality control (differentiation
and apoptosis assays) but also should pay attention to the
number of cells in microcarrier-cell-aggregates.The question
is whether a critical microcarrier-cell-aggregate size and
number of cells in the aggregate can be defined and used
as a harvest criterion for achieving maximum cell quantity
with desired cell quality in hMSC expansions. These studies
require subsequent investigations of diffusion limitations
and examination of cell viability on the perimeter of the
aggregates versus inside the aggregates.
Such findings represent one more step towards efficient
and robust hASC mass production processes, which are also
of interest for microcarrier-based, wave-mixed bioreactors,
for which the suspension criteria were determined at the first
time. An example of such a wave-mixed bioreactor is the
BIOSTAT CultiBag RM 2L, which allowed 2.85 × 108 hASCs
to be harvested after a proof-of-concept cultivation per-
formed at 𝑁𝑆1𝑢 conditions. Our established multiregression
model makes the rapid definition of the suspension criteria
for different working volumes possible and supports the
optimization of microcarrier-based, wave-mixed bioreactors
used for hASC cultivations. The consideration of further
microcarrier types in the regression model would even allow
hMSC expansions other than hASCs.
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𝑡: Time [s]
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Figure 8: Results from the proof-of-concept cultivation in a BIOSTAT CultiBag RM 2L. (a) Comparison of the expansion factors in the
BIOSTAT CultiBag RM 2L and the control spinner flask. The error bars represent the standard deviation. (b) DAPI staining picture of an
aggregate at the end of the cultivation in the BIOSTAT CultiBag RM 2L. White bare = 500 𝜇m.
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